Caplin Steriles receives USFDA approval for Ofloxacin Ophthalmic Solution USP 0.3%

Attention Investors

Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000. | Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors." | KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary." | ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

- EQUITY
  EQUITY
  PRICE
  
  Gainers & Losers
  
  Advances & Declines
  
  New Highs & Lows
  
  Index Movers
  
  Only Buyers/Sellers
  
  Out/Under Performers
- NEWS
  CORPORATE ACTIONS
  
  Announcements
  
  Book Closure
  
  Board Meetings
  
  Bonus Issues
  
  Rights Issues
  
  De-Listed Shares
  
  Market Turnover
  
  Change of Name
  
  Split of Face Value
- OTHER MARKETS
  FII Investments
  
  MF Investments
  
  ADR Prices
  
  World Indices
  
  Forex
  
  CORPORATE INFO
- VOLUME
  VOLUME
  Value & Volume Toppers
  
  Unusual Volume
  
  Bulk & Block Deals
  
  Sector Watch
- ANALYSIS
  ANALYSIS
  52 Week High Low
  
  Live Indices
  
  Exchange Holidays
  
  Index Constituents
  
  Historical Returns
  
  Circuit Breakers
- IPO
  IPO
  
  Forthcoming Issues
  
  Open Issues
  
  Closed Issues
  
  New Listing
  
  Basis of Allotment
  
  Draft Prospectus
  
  New Issue Monitor
  
  Best Performers
  
  Know IPO's / FAQ's

Monday, May 13, 2024 12:06:00 PM

Asian Paints

2873.30

(3.62%)

Axis Bank

1108.50

(-1.02%)

Bajaj Finance

6690.75

(0.08%)

Bajaj Finserv

1574.15

(0.06%)

Bharti Airtel

1290.85

(-0.90%)

HCL Technologi..

1311.70

(-0.35%)

HDFC Bank

1448.50

(0.76%)

Hind. Unilever

2360.00

(0.12%)

ICICI Bank

1114.60

(-0.19%)

IndusInd Bank

1385.25

(-1.73%)

Infosys

1415.70

(-0.66%)

ITC

432.75

(-0.10%)

JSW Steel

847.25

(-0.77%)

Kotak Mah. Ban..

1618.80

(-0.72%)

Larsen & Toubr..

3294.60

(0.71%)

M & M

2177.75

(-0.68%)

Maruti Suzuki

12557.95

(-0.93%)

Nestle India

2518.10

(-0.58%)

NTPC

352.75

(-0.83%)

Power Grid Cor..

303.80

(-0.03%)

Reliance Indus..

2793.50

(-0.77%)

St Bk of India

809.15

(-1.12%)

Sun Pharma.Ind..

1511.90

(0.38%)

Tata Motors

964.00

(-7.91%)

Tata Steel

161.85

(-0.31%)

TCS

3914.75

(0.49%)

Tech Mahindra

1259.80

(-0.42%)

Titan Company

3253.95

(-1.13%)

UltraTech Cem.

9503.00

(0.08%)

Wipro

449.00

(-0.60%)

	Equity Analysis

	News Analysis

	Corporate Actions

	Other Market

	Company Profile

Share Holding Pattern

Your results on : Equity | News | Company-News

Caplin Steriles receives USFDA approval for Ofloxacin Ophthalmic Solution USP 0.3%	Share Back
(16 Apr 2024)
Caplin Steriles, a Subsidiary Company of Caplin Point Laboratories has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ofloxacin Ophthalmic Solution USP 0.3% (eye drops), a generic therapeutic equivalent version of (RLD), OCUFLOX Ophthalmic Solution of Allergan Inc. Ofloxacin Ophthalmic Solution USP 0.3% is indicated for treatment of eye infections caused during the conditions of conjunctivitis and corneal ulcers. According to IQVIATM (IMS Health), Ofloxacin Ophthalmic Solution USP 0.3% had US sales of approximately $52 million for the 12- month period ending December 2023.
Top